Unfortunately, the use of these antiestrogens have undesirable side effects such as ICI 182,780 resulting in a complete blockade of activation pathways of ER and tamoxifen resulting in detrimental uterotrophic effects and can act as agonist for breast cancer cell growth [39], [40]. The gene discussed is ESR1; the disease is breast carcinoma.